259 related articles for article (PubMed ID: 31612059)
1. Evaluation of core serous epithelial ovarian cancer genes as potential prognostic markers and indicators of the underlying molecular mechanisms using an integrated bioinformatics analysis.
Zhang YB; Jiang Y; Wang J; Ma J; Han S
Oncol Lett; 2019 Nov; 18(5):5508-5522. PubMed ID: 31612059
[TBL] [Abstract][Full Text] [Related]
2. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
3. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
[TBL] [Abstract][Full Text] [Related]
4. Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis.
Wu K; Yi Y; Liu F; Wu W; Chen Y; Zhang W
Oncol Lett; 2018 Jul; 16(1):1003-1009. PubMed ID: 29963176
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
6. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis.
Yang X; Zhu S; Li L; Zhang L; Xian S; Wang Y; Cheng Y
Onco Targets Ther; 2018; 11():1457-1474. PubMed ID: 29588600
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
9. Identification of key pathways and candidate genes in pancreatic ductal adenocarcinoma using bioinformatics analysis.
He Y; Liu Y; Gong J; Liu C; Zhang H; Wu H
Oncol Lett; 2019 Apr; 17(4):3751-3764. PubMed ID: 30881497
[TBL] [Abstract][Full Text] [Related]
10. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
11. Identification of key genes and pathways in meningioma by bioinformatics analysis.
Dai J; Ma Y; Chu S; Le N; Cao J; Wang Y
Oncol Lett; 2018 Jun; 15(6):8245-8252. PubMed ID: 29805558
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of gene expression profiles to identify causal genes in luminal B2 breast cancer.
Wang J; Du Q; Li C
Oncol Lett; 2017 Dec; 14(6):7880-7888. PubMed ID: 29250180
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
Zhang L; Makamure J; Zhao D; Liu Y; Guo X; Zheng C; Liang B
Exp Ther Med; 2020 Jul; 20(1):427-435. PubMed ID: 32537007
[TBL] [Abstract][Full Text] [Related]
14. Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis.
Zou Z; Gan S; Liu S; Li R; Huang J
Oncol Lett; 2019 Jul; 18(1):916-926. PubMed ID: 31289570
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed genes and biological pathways in bladder cancer.
Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H
Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis to identify key genes and pathways influencing synovial inflammation in osteoarthritis.
Lin J; Wu G; Zhao Z; Huang Y; Chen J; Fu C; Ye J; Liu X
Mol Med Rep; 2018 Dec; 18(6):5594-5602. PubMed ID: 30365099
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
[TBL] [Abstract][Full Text] [Related]
18. Identification of candidate genes for the diagnosis and treatment of cholangiocarcinoma using a bioinformatics approach.
Zhou M; Zhu Y; Hou R; Mou X; Tan J
Oncol Lett; 2019 Nov; 18(5):5459-5467. PubMed ID: 31612054
[TBL] [Abstract][Full Text] [Related]
19. Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis.
Zhan SJ; Liu B; Linghu H
Oncol Rep; 2018 Jun; 39(6):2653-2663. PubMed ID: 29693178
[TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]